Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
42 Genetics
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Operaions<ref name=":0" />== <vimeo>515726155</vimeo> 1 in 17 people (7% of the population) will be affected by a rare disease at some point in their lives. This is about 3 million people in the UK. 80% of rare diseases include cancers, and some other well-known conditions such as cystic fibrosis and Huntington’s disease, have a genetic component. 42Genetics is on a mission to unlock genomic data for the world’s health organizations by providing data-driven solutions for diagnostics and discovery at scale. We are in negotiations with a life-science organization to progress precision medicine programs, enable high throughput diagnostics and accelerate the pace of research. A digitised human genome is 500GB in size when output from a sequencer and this makes it difficult to transfer through the Cloud and very costly to store, especially when working with large population groups. 42Genetics reduces the footprint to less than 5GB thus facilitating speed and making research more affordable. The Genomics industry was worth $18.85bn in 2019 and is projected to grow to $82.6bn by 2027. The team have significant experience in building genetic software, and in February 2020, we completed a validation project with Cambridge University, hosting and processing 15,000 whole genomes and achieving a publication in Nature journal along with NIHR and Genomics England.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)